Our Pipeline and Products

Menarini is investing in advanced science and technology to develop a pipeline of new products that make a difference to the lives of patients affected by serious conditions.

MENARINI is a fully integrated privately owned pharma company with a long and successful heritage in strategic partnering across the globe. We have a profound know-how stemming from our strong R&D capabilities in key therapeutic areas, coupled with our excellence in commercial execution and our powerful direct presence on a global basis.

Share your partnering idea

Our dedicated Corporate Business Development team is committed to assess and explore innovative new opportunities.

 

Donations of backpacks and cases for school, distribution of meals and medicines, promotion of sport, support for pregnant women and much more: being responsible for Menarini means transforming good intentions into concrete efforts. By helping others, we want to contribute to improve the world around us, starting with us.

Our Values

Everyday we put our values into action. 4 values, which have given life to Menarini and shaped its history.

 

What does it really make Menarini unique? The diversity and authenticity of our key resource - the People.
Our cultural diversity helps us to drive innovation, adapt to business changes, face challenges, inspire ideas and develop our growth.

Available positions on Linkedin

Menarini employees make all the difference, every day.

 

Congresses

ESCMID Global

2025/04/11-2025/04/15

Vienna, Austria

The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) is the leading Society for Clinical Microbiology and Infectious Diseases in Europe. In the wake of the COVID-19 pandemic, ESCMID now plays an important role in emerging infectious diseases and antimicrobial resistance education and research.
Leading experts in infectious diseases and clinical microbiology meet at ESCMID Global to exchange ideas and explore the latest innovations. ESCMID 2025 offers five days packed with keynote lectures, oral sessions, workshops, symposia, meet-the-expert sessions and poster presentations, making it the world’s most eminent event in the field of infection. Participation has been growing year on year with over 18K attendees in 2024.